Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder that primarily affects males who are carriers of a premutation of a CGG expansion in the FMR1 gene. In Asian populations, FXTAS has rarely been reported. Here, we report the case of a Japanese FXTAS patient who showed predominant executive cognitive deficits as the main feature of his disease. In contrast, the patient exhibited only very mild symptoms of intention tremor and ataxia, which did not interfere with daily activities. A gene analysis revealed that the patient carried a premutation of a CGG expansion (111 CGG repeats) in the FMR1 gene. The mRNA expression level of FMR1 in the patient was 1.5-fold higher than in controls. On brain MRI scans, fluid-attenuated inversion recovery images showed high-intensity lesions in the middle cerebellar peduncles and the cerebral white matter, with a frontal predominance. The present case extends previous notions regarding the cognitive impairment in FXTAS patients. Recognizing FXTAS patients with predominant cognitive impairment from various ethnic backgrounds would contribute to our understanding of the phenotypic variation of this disease.
Introduction
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder that primarily affects male carriers of a premutation expansion, ranging from 55 to 200 CGG repeats, in the FMR1 gene [1, 2] . The main features of FXTAS are intention tremor and gait ataxia. Less distinctive symptoms include parkinsonism, peripheral neuropathy, and cognitive decline [3] . Here, we report the case of a Japanese patient with a CGG premutation expansion in the FMR1 gene, who presented with predominant executive dysfunction and cerebral white matter lesions on MRI.
Case Report
A 59-year-old Japanese male patient first noticed occasional gait unsteadiness at the age of 44 years. The symptoms remained stable for a decade. There is no family history of mental retardation or neurological disease. His birth and early development were unremarkable. The patient gradually exhibited various cognitive symptoms including slowness in initiation and completion of simple tasks, excessive sleepiness during daytime, and poor concentration. He was referred to our hospital at the age of 59 years. On admission, detailed neuropsychological examinations were performed, the results of which are shown in table 1. General intellectual function, determined by the Wechsler Adult Intelligence Scale-III and Mini-Mental State Examination, was moderately impaired. The patient demonstrated poor performance in executive cognitive function tasks, examined by the Trail Making Test, Wisconsin Card Sorting Test, and Stroop test. His Frontal Assessment Battery score was also very low. Visual-spatial perception and language skills were preserved, and there were no signs of mood disorder or anxiety. On neurological examination, the patient showed mild intention tremor with terminal kinetic movement. His handwriting was well preserved. He showed mild truncal ataxia but was fully ambulant. There was no ataxia in his limbs, and muscle tendon reflexes in the extremities were attenuated. In addition, there was no sign of autonomic failure. On brain MRI, fluid-attenuated inversion recovery images showed high-intensity lesions in the middle cerebellar peduncles (MCPs) ( fig. 1a ). Prominent cerebral white matter hyperintensities with a frontal predominance were also noted ( fig. 1b, c ). In addition, atrophy was observed in the cerebral cortex and cerebellar hemispheres. 99m Tc-ethyl cysteinate dimer single-photon emission computed tomography revealed hypoperfusion in the cerebellum and the medial temporal lobe.
On the basis of these findings, we suspected that the patient suffered from FXTAS, although he exhibited minor motor symptoms and predominant cognitive symptoms. We determined the CGG repeat in the FMR1 gene using genomic DNA extracted from peripheral blood leukocytes as previously reported [4] . PCR analysis showed that the patient carried a premutation of a CGG expansion ( fig. 2a) . The size of the premutation determined by a fluorescent-sequencer method was 111 CGG repeats ( fig.  2b ). We next examined the FMR1 mRNA expression level in peripheral blood. SYBR green real-time PCR assay was performed as previously reported [5] . In our patient, the mRNA expression level of the FMR1 gene, normalized to that of β-glucoronidase, was 1.5-fold higher than in 4 male healthy controls.
Discussion
According to diagnostic criteria [2, 3] , the present case is defined as definite FXTAS, because the patient showed 2 clinical features (intention tremor and gait ataxia) as well as 1 major radiological finding (MCPs). However, motor dysfunction due to ataxia and tremor was very mild and did not interfere with activities of daily life. In contrast, the patient showed prominent executive cognitive deficits as the predominant feature of his disease.
In recent years, cognitive impairments in FXTAS patients have increasingly been investigated [6] [7] [8] . The cognitive phenotype of FXTAS is characterized by frontosubcortical dementia with impairment of executive functioning [9, 10] . It is as yet unknown when cognitive impairment begins in relation to the neurological signs of FXTAS. Gonçalves et al. [11] reported the case of a 70-year-old patient with atypical FXTAS, who presented rapidly progressive dementia as the major symptom. We here showed that our Japanese FXTAS patient exhibited frontal and executive dysfunctions characterized by psychomotor slowness, bradyphrenia, distractibility as well as attention and concentration difficulties. Prominent hyperintensities in the cerebral white matter with a frontal dominance might be attributable to the development of these manifestations in the patient. These findings extend the previous notions regarding the cognitive impairment associated with FXTAS.
Asian patients with FXTAS have rarely been reported in the literature. The exact reason for this is currently unknown. Recently, Ishii et al. [12] reported the first Japanese FXTAS patient who was initially diagnosed with essential tremor. Recognizing FXTAS patients with predominant cognitive impairment would contribute to our understanding of the disease's phenotypic variation. Genetic testing should be considered in patients with unidentified causes of cognitive impairment, particularly when an MRI shows hyperintensities in the cerebral white matter and/or MCPs. 
